SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001516551-22-000033
Filing Date
2022-10-03
Accepted
2022-10-03 17:14:53
Documents
14
Period of Report
2022-09-29
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K skye-20220929.htm   iXBRL 8-K 60732
2 EX-16.1 skyeletteroffriedmanllptos.htm EX-16.1 3110
3 EX-99.1 skye_093022xvotingresultsp.htm EX-99.1 13481
  Complete submission text file 0001516551-22-000033.txt   214386

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT skye-20220929.xsd EX-101.SCH 1921
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT skye-20220929_lab.xml EX-101.LAB 22080
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT skye-20220929_pre.xml EX-101.PRE 11526
8 EXTRACTED XBRL INSTANCE DOCUMENT skye-20220929_htm.xml XML 10700
Mailing Address 11250 EL CAMINO REAL, SUITE 100 SAN DIEGO CA 92130
Business Address 11250 EL CAMINO REAL, SUITE 100 SAN DIEGO CA 92130 (858) 410-0266
Skye Bioscience, Inc. (Filer) CIK: 0001516551 (see all company filings)

IRS No.: 450692882 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-55136 | Film No.: 221288486
SIC: 2834 Pharmaceutical Preparations